Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Aravive Inc | ARAV | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0401 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.04 - 2.3187 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.0401 | USD |
Aravive Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 2.95M | - | - | - | -3.87 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Aravive News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARAV Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.1216 | 0.127699 | 0.04 | 0.0680234 | 4,570,870 | -0.0815 | -67.02% |
6 Months | 0.132 | 0.285 | 0.04 | 0.1494578 | 5,299,706 | -0.0919 | -69.62% |
1 Year | 2.28 | 2.3187 | 0.04 | 0.2081479 | 4,405,874 | -2.24 | -98.24% |
3 Years | 6.55 | 6.94 | 0.04 | 0.5541029 | 1,454,052 | -6.51 | -99.39% |
5 Years | 7.33 | 29.60 | 0.04 | 1.24 | 921,774 | -7.29 | -99.45% |
Aravive Description
Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. Aravive's lead candidate is batiraxcept, which is is an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway. |